Globe Life Inc. (NYSE:GL – Get Free Report) EVP Robert Edward Hensley sold 712 shares of the company’s stock in a transaction that occurred on Wednesday, February 25th. The shares were sold at an average price of $142.59, for a total value of $101,524.08. Following the sale, the executive vice president owned 8,580 shares in the company, valued at $1,223,422.20. The trade was a 7.66% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website.
Globe Life Stock Performance
Shares of GL traded down $0.77 during mid-day trading on Friday, hitting $145.32. The stock had a trading volume of 504,950 shares, compared to its average volume of 513,973. Globe Life Inc. has a fifty-two week low of $109.38 and a fifty-two week high of $152.71. The company has a quick ratio of 0.07, a current ratio of 0.07 and a debt-to-equity ratio of 0.41. The company has a market cap of $11.57 billion, a PE ratio of 10.32 and a beta of 0.47. The company’s fifty day simple moving average is $141.76 and its two-hundred day simple moving average is $138.69.
Globe Life (NYSE:GL – Get Free Report) last released its quarterly earnings data on Wednesday, February 4th. The company reported $3.39 EPS for the quarter, missing analysts’ consensus estimates of $3.44 by ($0.05). Globe Life had a return on equity of 21.75% and a net margin of 19.37%.The business had revenue of $1.52 billion during the quarter, compared to analyst estimates of $1.53 billion. During the same period in the prior year, the firm earned $3.14 EPS. The business’s revenue for the quarter was up 3.6% compared to the same quarter last year. Globe Life has set its FY 2026 guidance at 14.950-15.650 EPS. On average, equities analysts expect that Globe Life Inc. will post 13.87 earnings per share for the current year.
Globe Life Increases Dividend
Wall Street Analyst Weigh In
Several equities research analysts have weighed in on GL shares. Morgan Stanley reaffirmed an “overweight” rating and issued a $176.00 target price on shares of Globe Life in a research report on Monday, December 15th. JPMorgan Chase & Co. increased their price objective on shares of Globe Life from $180.00 to $181.00 and gave the stock an “overweight” rating in a report on Thursday, February 5th. Piper Sandler reissued an “overweight” rating and set a $167.00 target price on shares of Globe Life in a research note on Friday, November 21st. Wells Fargo & Company upped their target price on shares of Globe Life from $170.00 to $171.00 and gave the stock an “overweight” rating in a research report on Wednesday. Finally, Evercore set a $157.00 price target on shares of Globe Life in a research note on Wednesday, February 18th. Eight equities research analysts have rated the stock with a Buy rating and two have given a Hold rating to the company’s stock. According to MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average price target of $171.33.
Check Out Our Latest Stock Analysis on GL
Key Globe Life News
Here are the key news stories impacting Globe Life this week:
- Positive Sentiment: Board raised the quarterly dividend to $0.33 (22.2% increase) and announced two new board members — supports income-focused investors and signals confidence in cash flow. GLOBE LIFE INC. DECLARES DIVIDEND AND ANNOUNCES APPOINTMENT OF TWO NEW BOARD MEMBERS
- Positive Sentiment: Wells Fargo published a positive price-forecast note on Globe Life, which can attract buyers and lend near-term support to the share price. Wells Fargo & Company Issues Positive Forecast for Globe Life (NYSE:GL) Stock Price
- Neutral Sentiment: Globe Life Field booked for an Eagles concert, which forced a local high school to reschedule prom — shows strong event demand and venue utilization but has minimal direct impact on insurance operations. Eagles concert at Globe Life Field moves Texas high school’s prom night date How an Eagles concert at Globe Life Field bumped a North Texas high school prom
- Neutral Sentiment: GL was included in a Zacks piece highlighting high-ROE stocks as resilient plays; such coverage may raise investor interest but is not a company-specific catalyst. Buy 5 Stocks With High ROE as Markets Dance Whimsically to the AI Tune
- Negative Sentiment: CEO James Matthew Darden sold 9,527 shares (~15% reduction in his reported ownership), a sizable insider sale that can spook some investors. SEC Form 4 – Darden sale
- Negative Sentiment: EVP Robert Edward Hensley sold 712 shares (~7.7% reduction in his holding), another insider sale that adds to selling pressure signals. SEC Form 4 – Hensley sale
- Negative Sentiment: TipRanks flagged Globe Life’s rising allocation to alternative assets as increasing volatility, capital strain and liquidity risk — a potential medium-term headwind for valuation if realized. Globe Life’s Growing Alternative Asset Bets Raise Volatility, Capital Strain and Liquidity Risk
Institutional Investors Weigh In On Globe Life
Institutional investors and hedge funds have recently added to or reduced their stakes in the business. Norges Bank acquired a new position in shares of Globe Life during the 2nd quarter worth approximately $157,722,000. Northwestern Mutual Wealth Management Co. increased its holdings in Globe Life by 34,786.0% during the fourth quarter. Northwestern Mutual Wealth Management Co. now owns 881,919 shares of the company’s stock worth $123,345,000 after buying an additional 879,391 shares during the last quarter. AQR Capital Management LLC increased its holdings in Globe Life by 98.6% during the second quarter. AQR Capital Management LLC now owns 1,402,690 shares of the company’s stock worth $174,340,000 after buying an additional 696,548 shares during the last quarter. Balyasny Asset Management L.P. bought a new stake in Globe Life during the third quarter worth $80,925,000. Finally, Westfield Capital Management Co. LP acquired a new stake in Globe Life in the third quarter valued at $61,569,000. 81.61% of the stock is owned by institutional investors.
Globe Life Company Profile
Globe Life, traded on the NYSE under the symbol GL, is a U.S.-based insurance holding company that underwrites and distributes a range of life and supplemental health insurance products. Through its subsidiary brands—Globe Life, American Income Life, Liberty National Life, United American Insurance Company and Family Heritage Life—it offers term life, whole life, fixed annuities and supplemental health coverage designed to meet the needs of individuals and families across various socioeconomic segments.
The company’s product suite includes low-cost, easy-to-understand life insurance policies, accidental death and dismemberment coverage, hospital indemnity plans and specified disease insurance.
Recommended Stories
- Five stocks we like better than Globe Life
- The gold chart Wall Street is terrified of…
- America’s 1776 happening again
- This makes me furious
- Buy this Gold Stock Before May 2026
- What a Former CIA Agent Knows About the Coming Collapse
Receive News & Ratings for Globe Life Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Globe Life and related companies with MarketBeat.com's FREE daily email newsletter.
